CDH1 and cancer: On the other hand, changes in E-cadherin (CDH1) are not consistent with the known changes in the EMT process, since progression of cancer development is accompanied by cell–cell contact inhibition and high invasiveness, resulting from reduced intercellular adhesion [23].